Analystreport

Bioblast Pharma Ltd (NASDAQ: ORPN) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating.

BIO BLAST PHARMA LTD ORDINARY  (ORPN) 
Last bio blast pharma ltd ordinary earnings: 5/26 04:15 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.bioblastpharma.com/investor-overview-0